FALLON HOUK: Open Payments
NPI 1417628728 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 42 payments from 13 companies in 2025. Trend: 2023 $116 · 2024 $962 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $359 |
| Novo Nordisk Inc | 9 | $146 |
| Sumitomo Pharma America, Inc. | 2 | $75 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Medtronic, Inc. | 1 | $30 |
| PFIZER INC. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $30 |
| Dynavax Technologies Corporation | 1 | $25 |
| Boston Scientific Corporation | 1 | $25 |
| Organon LLC | 1 | $21 |
Products named: VRAYLAR, Wegovy, GEMTESA, Ozempic, INTELLIS ADAPTIVESTIM, NURTEC ODT, Veozah, Heplisav-B.
Industry payments across GA — which companies pay providers there.
